Akero Therapeutics, Inc.
AKRO
$48.43
$0.400.83%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 742.32M | 686.29M | 743.08M | 717.25M | 760.19M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 22.29M | 26.86M | 27.30M | 29.64M | 15.82M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 764.60M | 713.15M | 770.38M | 746.89M | 776.01M |
|
|
|||||
| Total Current Assets | 764.60M | 713.15M | 770.38M | 746.89M | 776.01M |
| Net Property, Plant & Equipment | 621.00K | 689.00K | 755.00K | 835.00K | 900.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.11B | 1.16B | 825.89M | 817.55M | 865.04M |
|
|
|||||
| Total Accounts Payable | 13.25M | 10.83M | 9.03M | 25.22M | 14.57M |
| Total Accrued Expenses | 32.50M | 24.30M | 30.10M | 17.44M | 15.98M |
| Short-term Debt | -- | 6.66M | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 13.87M | 299.00K | 291.00K | 283.00K | 275.00K |
| Total Finance Division Other Current Liabilities | 784.00K | 346.00K | 340.00K | 348.00K | 354.00K |
| Total Other Current Liabilities | 784.00K | 346.00K | 340.00K | 348.00K | 354.00K |
| Total Current Liabilities | 60.40M | 42.44M | 39.75M | 43.29M | 31.17M |
|
|
|||||
| Total Current Liabilities | 60.40M | 42.44M | 39.75M | 43.29M | 31.17M |
| Long-Term Debt | 22.16M | 28.81M | 35.30M | 35.12M | 34.96M |
| Short-term Debt | -- | 6.66M | -- | -- | -- |
| Capital Leases | 372.00K | 451.00K | 529.00K | 605.00K | 679.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 400.00K | 296.00K | 194.00K | 203.00K | 164.00K |
| Total Liabilities | 83.33M | 72.00M | 75.77M | 79.22M | 66.98M |
|
|
|||||
| Common Stock & APIC | 1.99B | 1.98B | 1.58B | 1.49B | 1.48B |
| Retained Earnings | -967.39M | -896.88M | -826.16M | -756.13M | -683.43M |
| Treasury Stock & Other | 988.00K | 1.09M | 948.00K | 2.10M | -261.00K |
| Total Common Equity | 1.03B | 1.08B | 750.11M | 738.33M | 798.07M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.03B | 1.08B | 750.11M | 738.33M | 798.07M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.03B | 1.08B | 750.11M | 738.33M | 798.07M |
|
|
|||||